References:
  1. Olsen L, Sparsø T, Weinsheimer SM, et al. Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study. Lancet Psychiatry 2018;5 :573-80.
  2. Fung WL, Butcher NJ, Costain G, et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet Med 2015;17 :599-609.
  3. Habel A, Herriot R, Kumararatne D, et al. Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times. Eur J Pediatr. 2014;173 :757-65.
  4. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370 :1443-52.
  5. Unolt M, Versacci P, Anaclerio S, et al. Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers. Am J Med Genet A 2018;176 :2087-98.
  6. Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 2010;11 :402-16.
  7. Constance LSL, Lansing MG, Khor FK, et al. Schizophrenia and anaesthesia. BMJ Case Rep 2017;23 :bcr2017221659.
  8. AlQarni MA, Alharbi A, Merdad L. Dental management of a patient with 22q11.2 deletion syndrome (22q11.2DS). BMJ Case Rep 2018;18 :bcr2018225765.